跳至主要内容
临床试验/CTRI/2017/10/010001
CTRI/2017/10/010001已完成3 期

Efficacy & safety of standard Vs high flow rates of Nasal High Flow therapy in very preterm neonates- A randomized controlled trial

Surya Children Hospital0 个研究点目标入组 210 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
210

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Preterm infants more than 28 weeks of gestation and/or more than 1 kg birth weight with respiratory distress and FiO2 requirement >30% within first 6 hours of birth.

排除标准

  • 1) Birth weight <1000 grams
  • 2)Gestational age <28 weeks
  • 3)Infant who already received surfactant
  • 4)Pneumothorax on Chest X-ray
  • 5)Shock requiring inotropic support, multi organ dysfunction and encephalopathy
  • 6)Abnormalities of upper and lower airways precluding use of HHHFNC (Pierre-Robin, Treacher Collins, Goldenhar, choanal atresia, cleft lip/palate)
  • 7)Serious abdominal, cardiac, or respiratory malformations including tracheal esophageal fistula, intestinal atresia, omphalocele, gastroschisis, or diaphragmatic hernia.

研究者

相似试验